eMed is a Miami, Florida-based digital healthcare startup that was established on August 18, 2020. With an emphasis on type 2 diabetes and obesity, it focuses in offering AI-powered solutions for managing chronic diseases.

The Empathetic AITM Population Health Platform, the platform’s main product, combines human oversight with AI-driven predictive analytics to provide individualized treatment. Virtual proctoring around-the-clock, AI biometric capture tools, supervised at-home blood collection, and adherence monitoring via weekly check-ins and dosage management are some of the salient features.

More than 6 million people use eMed’s services worldwide, including more than 1,200 businesses and governmental organizations. The company focuses on lowering auxiliary medical services and improving adherence in order to cut healthcare expenses by up to 50%.